Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23405869)

1.

AMPA receptor positive allosteric modulators: a patent review.

Pirotte B, Francotte P, Goffin E, de Tullio P.

Expert Opin Ther Pat. 2013 May;23(5):615-28. doi: 10.1517/13543776.2013.770840. Epub 2013 Feb 13. Review.

PMID:
23405869
2.

Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators.

Pirotte B, Francotte P, Goffin E, Fraikin P, Danober L, Lesur B, Botez I, Caignard DH, Lestage P, de Tullio P.

Curr Med Chem. 2010;17(30):3575-82. Review.

PMID:
20738245
3.

In search of novel AMPA potentiators.

Francotte P, de Tullio P, Fraikin P, Counerotte S, Goffin E, Pirotte B.

Recent Pat CNS Drug Discov. 2006 Nov;1(3):239-46. Review.

PMID:
18221205
4.

DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.

Bernard K, Danober L, Thomas JY, Lebrun C, Muñoz C, Cordi A, Desos P, Lestage P, Morain P.

CNS Neurosci Ther. 2010 Oct;16(5):e193-212. doi: 10.1111/j.1755-5949.2009.00088.x.

PMID:
21050420
6.

[Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].

Raevskiĭ KS, Eremin KO.

Biomed Khim. 2004;50(6):523-38. Review. Russian.

PMID:
15707268
7.

Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease.

Yamada KA.

Expert Opin Investig Drugs. 2000 Apr;9(4):765-78. Review.

PMID:
11060708
8.

S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.

Lockhart BP, Rodriguez M, Mourlevat S, Peron P, Catesson S, Villain N, Galizzi JP, Boutin JA, Lestage P.

Eur J Pharmacol. 2007 Apr 30;561(1-3):23-31. Epub 2007 Feb 1.

PMID:
17331496
9.

AMPA receptor potentiators for the treatment of CNS disorders.

O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES.

Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):181-94. Review.

PMID:
15180479
10.

Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors.

Siuda ER, Quirk JC, Nisenbaum ES.

Methods Mol Biol. 2007;403:37-57. doi: 10.1007/978-1-59745-529-9_3.

PMID:
18827986
11.

Recent advances in positive allosteric modulators of the AMPA receptor.

Morrow JA, Maclean JK, Jamieson C.

Curr Opin Drug Discov Devel. 2006 Sep;9(5):571-9. Review.

PMID:
17002217
12.

Challenges for and current status of research into positive modulators of AMPA receptors.

Ward SE, Bax BD, Harries M.

Br J Pharmacol. 2010 May;160(2):181-90. doi: 10.1111/j.1476-5381.2010.00726.x. Review.

13.
14.

AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook.

Chang PK, Verbich D, McKinney RA.

Eur J Neurosci. 2012 Jun;35(12):1908-16. doi: 10.1111/j.1460-9568.2012.08165.x. Review.

PMID:
22708602
15.

Recent advances in the discovery of selective AMPA receptor positive allosteric modulators.

Ward SE, Harries M.

Curr Med Chem. 2010;17(30):3503-13. Review.

PMID:
20738249
16.

mGluR2 positive allosteric modulators: a patent review (2009 - present).

Trabanco AA, Cid JM.

Expert Opin Ther Pat. 2013 May;23(5):629-47. doi: 10.1517/13543776.2013.777043. Epub 2013 Mar 2. Review.

PMID:
23452205
17.

Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature.

Lindsley CW, Hopkins CR.

Expert Opin Ther Pat. 2012 May;22(5):461-81. doi: 10.1517/13543776.2012.679437. Epub 2012 Apr 16. Review.

PMID:
22506633
18.

A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents.

Chen H, Wang CZ, Ding C, Wild C, Copits B, Swanson GT, Johnson KM, Zhou J.

ChemMedChem. 2013 Feb;8(2):226-30. doi: 10.1002/cmdc.201200554. Epub 2012 Dec 20.

19.

Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.

Woolley ML, Waters KA, Gartlon JE, Lacroix LP, Jennings C, Shaughnessy F, Ong A, Pemberton DJ, Harries MH, Southam E, Jones DN, Dawson LA.

Psychopharmacology (Berl). 2009 Jan;202(1-3):343-54. doi: 10.1007/s00213-008-1325-2. Epub 2008 Sep 16.

PMID:
18795266
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk